Literature DB >> 11332657

The neuroimmunology of multiple sclerosis: possible roles of T and B lymphocytes in immunopathogenesis.

K C O'Connor1, A Bar-Or, D A Hafler.   

Abstract

Multiple sclerosis (MS) is an inflammatory disease of the central nervous system white matter. The association of the disease with MHC genes, the inflammatory white matter infiltrates, similarities with animal models, and the observation that MS can be treated with immunomodulatory and immunosuppressive therapies support the hypothesis that autoimmunity plays a major role in the disease pathology. Evidence supports activated CD4+ myelin-reactive T cells as major mediators of the disease. In addition, a renewed interest in the possible contribution of B cells to MS immunopathology has been sparked by nonhuman primate and MS pathological studies. This review focuses on the immunopathology of MS, outlining the hypothetical steps of tolerance breakdown and the molecules that play a role in the migration of autoreactive cells to the CNS. Particular focus is given to autoreactive T cells and cytokines as well as B cells and autoantibodies and their role in CNS pathogenesis in MS.

Entities:  

Mesh:

Year:  2001        PMID: 11332657     DOI: 10.1023/a:1011064007686

Source DB:  PubMed          Journal:  J Clin Immunol        ISSN: 0271-9142            Impact factor:   8.317


  142 in total

1.  Decreased dependence of myelin basic protein-reactive T cells on CD28-mediated costimulation in multiple sclerosis patients. A marker of activated/memory T cells.

Authors:  A E Lovett-Racke; J L Trotter; J Lauber; P J Perrin; C H June; M K Racke
Journal:  J Clin Invest       Date:  1998-02-15       Impact factor: 14.808

2.  Oligoclonal immunoglobulins and plasma cells in spinal fluid of patients with multiple sclerosis.

Authors:  E J Thompson; P Kaufmann; R C Shortman; P Rudge; W I McDonald
Journal:  Br Med J       Date:  1979-01-06

3.  Matrix metalloproteinases in the normal human central nervous system, microglial nodules, and multiple sclerosis lesions.

Authors:  A Maeda; R A Sobel
Journal:  J Neuropathol Exp Neurol       Date:  1996-03       Impact factor: 3.685

4.  An extensive search for autoantibodies to myelin basic protein in cerebrospinal fluid of non-multiple-sclerosis patients: implications for the pathogenesis of multiple sclerosis.

Authors:  K G Warren; I Catz
Journal:  Eur Neurol       Date:  1999       Impact factor: 1.710

5.  Clonal expansion and somatic hypermutation of V(H) genes of B cells from cerebrospinal fluid in multiple sclerosis.

Authors:  Y Qin; P Duquette; Y Zhang; P Talbot; R Poole; J Antel
Journal:  J Clin Invest       Date:  1998-09-01       Impact factor: 14.808

6.  B-cell-deficient mice develop experimental allergic encephalomyelitis with demyelination after myelin oligodendrocyte glycoprotein sensitization.

Authors:  P Hjelmström; A E Juedes; J Fjell; N H Ruddle
Journal:  J Immunol       Date:  1998-11-01       Impact factor: 5.422

Review 7.  Cerebrospinal fluid in the diagnosis of multiple sclerosis: a consensus report.

Authors:  M Andersson; J Alvarez-Cermeño; G Bernardi; I Cogato; P Fredman; J Frederiksen; S Fredrikson; P Gallo; L M Grimaldi; M Grønning
Journal:  J Neurol Neurosurg Psychiatry       Date:  1994-08       Impact factor: 10.154

8.  Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis.

Authors:  D O Willenborg; S J Prowse
Journal:  J Neuroimmunol       Date:  1983-10       Impact factor: 3.478

9.  Anti-cardiolipin antibodies in neurological disorders: cross-reaction with anti-single stranded DNA activity.

Authors:  C B Colaço; G K Scadding; S Lockhart
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

10.  Oligodendrocyte-specific expression and autoantigenicity of transaldolase in multiple sclerosis.

Authors:  K Banki; E Colombo; F Sia; D Halladay; D H Mattson; A H Tatum; P T Massa; P E Phillips; A Perl
Journal:  J Exp Med       Date:  1994-11-01       Impact factor: 14.307

View more
  47 in total

1.  An increase in CD4+CD25+FOXP3+ regulatory T cells in tumor-infiltrating lymphocytes of human glioblastoma multiforme.

Authors:  Abdeljabar El Andaloussi; Maciej S Lesniak
Journal:  Neuro Oncol       Date:  2006-05-24       Impact factor: 12.300

2.  Genetic Susceptibility to Multiple Sclerosis: The Role of FOXP3 Gene Polymorphism.

Authors:  Nihal Işik; Nüket Yildiz Manukyan; İlknur Aydin Cantürk; Fatma Candan; Ayşen Ünsal Çakmak; Güher Saru Han Direskeneli
Journal:  Noro Psikiyatr Ars       Date:  2014-03-01       Impact factor: 1.339

3.  Targeting effector memory T cells with a selective peptide inhibitor of Kv1.3 channels for therapy of autoimmune diseases.

Authors:  Christine Beeton; Michael W Pennington; Heike Wulff; Satendra Singh; Daniel Nugent; George Crossley; Ilya Khaytin; Peter A Calabresi; Chao-Yin Chen; George A Gutman; K George Chandy
Journal:  Mol Pharmacol       Date:  2005-01-21       Impact factor: 4.436

4.  A granulocyte-macrophage colony-stimulating factor and interleukin-15 fusokine induces a regulatory B cell population with immune suppressive properties.

Authors:  Moutih Rafei; Jeremy Hsieh; Simone Zehntner; Mengyang Li; Kathy Forner; Elena Birman; Marie-Noëlle Boivin; Yoon Kow Young; Claude Perreault; Jacques Galipeau
Journal:  Nat Med       Date:  2009-08-09       Impact factor: 53.440

5.  N-Terminally extended analogues of the K⁺ channel toxin from Stichodactyla helianthus as potent and selective blockers of the voltage-gated potassium channel Kv1.3.

Authors:  Shih C Chang; Redwan Huq; Sandeep Chhabra; Christine Beeton; Michael W Pennington; Brian J Smith; Raymond S Norton
Journal:  FEBS J       Date:  2015-04-23       Impact factor: 5.542

Review 6.  New approaches in the management of multiple sclerosis.

Authors:  Laurie J Barten; Douglas R Allington; Kendra A Procacci; Michael P Rivey
Journal:  Drug Des Devel Ther       Date:  2010-11-24       Impact factor: 4.162

7.  Antigen specificity of clonally expanded and receptor edited cerebrospinal fluid B cells from patients with relapsing remitting MS.

Authors:  Doris Lambracht-Washington; Kevin C O'Connor; Elizabeth M Cameron; Andrea Jowdry; E Sally Ward; Elliot Frohman; Michael K Racke; Nancy L Monson
Journal:  J Neuroimmunol       Date:  2007-04-23       Impact factor: 3.478

8.  The voltage-gated Kv1.3 K(+) channel in effector memory T cells as new target for MS.

Authors:  Heike Wulff; Peter A Calabresi; Rameeza Allie; Sung Yun; Michael Pennington; Christine Beeton; K George Chandy
Journal:  J Clin Invest       Date:  2003-06       Impact factor: 14.808

9.  Interaction of disease-related antigen-reactive T-cell lines from multiple sclerosis patients with type IV collagen: role of integrin VLA-1 and effects of irradiation.

Authors:  Ilan Bank; Anat Achiron; Gad Levie; Alexander Koltakov; Mathilda Mandel
Journal:  J Clin Immunol       Date:  2002-05       Impact factor: 8.317

10.  Claudin Proteins And Neuronal Function.

Authors:  Jérôme Devaux; Bozena Fykkolodziej; Alexander Gow
Journal:  Curr Top Membr       Date:  2010       Impact factor: 3.049

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.